COVID Conversations: Sarah Gilbert on Vaccines

Professor Gilbert has been a part of Oxford’s vaccine community since 1994, working closely with Professor Adrian Hill, Director of the Jenner Institute. Receiving her professorship in 2010, Gilbert has spent the past decade and a half working on novel influenza vaccinations. Now, she’s working on a modified version of the ChAdOx1 vaccine (ChAdOx1 nCoV-19) to counteract the COVID-19 pandemic. Thanks to previous work in this area and the efforts of Oxford colleagues, her team have been able to condense their timelines in developing a vaccine considerably – reducing a timeline of about five years in normal conditions to three months. This vaccine is already entering into human trials, and will rapidly progress through its Phase II/III studies throughout the spring and summer months of 2020, with a potential candidate ready to go by the autumn. So send in your questions for Sarah, and we’ll try to get through as many as we can!
Please Support Now: Oxford has over 150 researchers working on the urgent response to the Coronavirus outbreak. Public donations of any size will be rapidly put to use in our frontline research. You can make a gift today at http://www.research.ox.ac.uk/giving
To find more talks in our Covid Conversations series, go to https://bit.ly/COVIDconversations